2025 ESC Guidelines for the management of #myocarditis and #pericarditis #ESCCongress #HeartFailure #HFA_ESC European Society of Cardiology Novi Yanti Sari Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 rafavidalperez Hany Ragy Javed Butler Mamas A. Mamas

NEW #ESCGuidelines on #myocarditis and #pericarditis: ow.ly/RgJS50WNYqp

When should we downtitrate or stop GDMT in #HFrEF? 🫀 ⚠️Depends on phenotype & clinical context, as summarized by Prof BiykemBozkurt: 📍Recovered/cured HF➡️individualized, may consider de-escalation 📍Improving/remission➡️continue & optimize GDMT 📍Persistent/worsening➡️escalate,

And the debate continues PhysioSync trial ⬇️⬇️⬇️ CSP is inferior to BiVP for CRT in HFrEF and LBBB (QRSD ≥ 130 msec) including HF events, LVEF improvement and death #EPeeps #ESCCongress

Day 1 at #ESCCongress has been full of energy, and inspiring science. Always a highlight to see how much innovation is happening in cardiology and to reconnect with so many familiar faces. Looking forward to the next few days of learning and discussions here in Madrid!

Latest European Society of Cardiology 2025 Guidelines: 1️⃣ Dyslipidemia academic.oup.com/eurheartj/adva… 2️⃣ Pregnancy & CVD academic.oup.com/eurheartj/adva… 3️⃣ Mental Health & CVD academic.oup.com/eurheartj/adva… 4️⃣ Valvular Heart Disease academic.oup.com/eurheartj/adva… 5️⃣ Myocarditis & Pericarditis

A real world analysis of tafamidis outcomes still shows the increased mortality in #ATTR #CM #ESC2025 #CardioTwitter #MedIQESCCongress

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure #LBCT #ESCCongress #WCCongress 2025 🫀1:1 RCT of Dapa 🆚 Placebo 🫀34% female, 19% Black 🫀SGLT2i is safe in acute hospitalization but no significant difference in primary outcome of

#VICTOR #ESCCongress #LBCT 🫀Vericiguat in Chronic #HFrEF 🫀population:1/2 no prior HF hospitalization, excellent GDMT 🫀 Nonetheless, no significant finding of difference of Vericiguat 🆚 Placebo 🫀did ⤵️ risk of CV death

🔥DAPA ACT HF-TIMI 68 trial results Fresh from #ESCCongress 📍No significant ⬇️ in #CVdeath or worsening HF at 2 months with in-hospital #Dapagliflozin ⚠️But‼️ 📍 Meta-analysis with other RCTs: early in-hospital #SGLT2i initiation ⬇️ adverse outcomes including #CVdeath &

❓Can #NTproBNP guide early cardioprotection in #cancer pts? 🧪#NTproBNP_Guide trial: #BreastCA & #lymphoma pts on #anthracyclines, randomized to #NTproBNP guided neurohormonal therapy 🆚 usual care 📍NT-proBNP–guided strategy was feasible & safe 📍Led to modest early LVEF

🔥 #VICTOR + #VICTORIA 💡 #Vericiguat Results are published, interpretations are more complex My take: 1. #Vericiguat is an effective & safe drug in #WorseningHF #Tweetorial 📜⬇️

#Sacubitril-#Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II RCT #PRADA II 🫀 in breast cancer pts on anthracyclines: 📌LVEF ↓: -1.1% (sac/val) vs -2.2% (placebo) 📌Strain: stable (Δ -0.32) vs worsening (+0.53) 📌NT-proBNP ↑

Prophylactic ICD therapy did not 🚫 reduce mortality in patients with a prior MI, persistent moderate LV systolic dysfunction and abnormal ECG markers🚩, based on findings from REFINE-ICD presented at #ESCCongress. ➡️ Read the news story: bit.ly/4n2InNP

MAPLE-HCM montre que l’aficamten, en 1ʳᵉ ligne, améliore symptômes, capacité fonctionnelle, gradient intra-VG, NT-proBNP et volume OG vs métoprolol chez les patients CMH obstructive. L'article de Charles Fauvel & Jeremy Florence du CCF : cardio-online.fr/actualites/cou…

Everything you need to know about pharmacotherapy in #HFpEF 💊 Presented by the only one Harriette Van Spall, MD MPH 🇨🇦 📍#HFpEF reframed: part of the cardiometabolic–renal (#CKM) syndrome 📍Ongoing studies will refine role of #finerenone, #spironolactone, & combination therapies 📍A paradigm

💔 Heart failure–related deaths in Europe rose from 2012 to 2021. Significant disparities remain across regions and countries. #HeartFailure #EuropeanUnion #EJHF ow.ly/7HaS50WNmWx EJHF Editor-in-Chief Amr Abdin Giuseppe Galati Henry Han

Les cardiologues défendent l’usage des statines face aux critiques du ministre - lespecialiste.be/fr/actualites/…

Clôture des #JFICCAT2025 à Poitiers ! Discussions passionnantes sur l’IA, la télémédecine et les approches diagnostiques & thérapeutiques innovantes en insuffisance cardiaque. Un grand merci au GICC pour ce congrès inspirant ! #Cardiologie #insuffisancecardiaque

Les cardiologues défendent l’usage des statines face aux déclarations de Mr Vandenbroucke. Ces propos qui risquent de pousser certains patients à interrompre leur traitement. RTL info Le Soir La Libre @bscardio #Santé #politique #Prévention #Belgique lespecialiste.be/fr/actualites/…